Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
Angelini Ventures has already invested €125 million in 22 startups
Subscribe To Our Newsletter & Stay Updated